IE45491L - Prostaglandin analogues - Google Patents

Prostaglandin analogues

Info

Publication number
IE45491L
IE45491L IE770011A IE1177A IE45491L IE 45491 L IE45491 L IE 45491L IE 770011 A IE770011 A IE 770011A IE 1177 A IE1177 A IE 1177A IE 45491 L IE45491 L IE 45491L
Authority
IE
Ireland
Prior art keywords
trans
configuration
prostaglandin analogues
compounds
prostaglandin
Prior art date
Application number
IE770011A
Other versions
IE45491B1 (en
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/646,316 external-priority patent/US4052512A/en
Priority claimed from GB1598276A external-priority patent/GB1540427A/en
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Publication of IE45491L publication Critical patent/IE45491L/en
Publication of IE45491B1 publication Critical patent/IE45491B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C391/00—Compounds containing selenium
    • C07C391/02—Compounds containing selenium having selenium atoms bound to carbon atoms of six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/02—Lithium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5407—Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials Engineering (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PURPOSE:Prostaglandin-like compounds of formula I (R is H, 1-4C alkyl; dotted lines represent bonding of OH group in alpha-or beta-configuration; the double bonds at C2-C3 and C14-C14 are trans-configuration), or clathrate compounds thereof in cyclodextrin, or non-toxic salts thereof when R is H; for example, 9-oxo-11alpha, 15alpha-dihydroxy-16, 16-dimethylprosta-trans-2,trans-13dienoic acid. [JP52085151A]
IE11/77A 1976-01-05 1977-01-04 Prostagladin analogues IE45491B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/646,316 US4052512A (en) 1976-01-05 1976-01-05 Prostaglandin analogues
GB1598276A GB1540427A (en) 1972-12-29 1976-04-20 Prostaglandin analogues

Publications (2)

Publication Number Publication Date
IE45491L true IE45491L (en) 1977-07-05
IE45491B1 IE45491B1 (en) 1982-09-08

Family

ID=26251676

Family Applications (1)

Application Number Title Priority Date Filing Date
IE11/77A IE45491B1 (en) 1976-01-05 1977-01-04 Prostagladin analogues

Country Status (6)

Country Link
JP (1) JPS5285151A (en)
AU (1) AU512644B2 (en)
DK (1) DK146025C (en)
IE (1) IE45491B1 (en)
LU (1) LU76513A1 (en)
NZ (1) NZ182968A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201809622VA (en) 2016-05-09 2018-11-29 Agc Inc Novel prostaglandin derivative
WO2019087948A1 (en) 2017-10-31 2019-05-09 Ａｇｃ株式会社 Method for producing prostaglandin derivative

Also Published As

Publication number Publication date
DK146025B (en) 1983-05-30
LU76513A1 (en) 1977-07-14
JPS5761276B2 (en) 1982-12-23
DK146025C (en) 1983-10-24
IE45491B1 (en) 1982-09-08
DK2577A (en) 1977-07-06
JPS5285151A (en) 1977-07-15
AU2104477A (en) 1978-07-13
NZ182968A (en) 1978-12-18
AU512644B2 (en) 1980-10-23

Similar Documents

Publication Publication Date Title
IE40157B1 (en) Prostanoic acid derivatives
JPS56158760A (en) Prostaglandin analog compound, its preparation and drug composition containing the same
GB1373461A (en) Tetrazoyl derivatives of naturally occuring prostaglandins
EP0038614A3 (en) Esters of 5- and 6-oxo-prostaglandins
JPS5444639A (en) Prostaglandin analog and its preparation
GB1488006A (en) Prostaglandin analogues
IE45491L (en) Prostaglandin analogues
IE40977B1 (en) Prostaglandin compositions
JPS52143217A (en) Stable composition containing prostaglandi ne
IE37909L (en) Prostaglandin analogues
IE41535L (en) Prostanoic acid derivatives
IE42933L (en) Glyoxylic acid derivatives.
JPS57206616A (en) Menses inducer, feticidal or odynopoeia containing prostaglandin e1 analog
GB1449882A (en) Prostaglandin analogues
IE45606L (en) Prostanoic acid derivatives
IE45634L (en) Prostane derivatives
IE44161L (en) Prostaglandin analogues
JPS5340742A (en) Prostagilandin analogues, their preparation and medical composition containing the same as active constituents
JPS5297943A (en) Prostaglandin derivatives
JPS5236646A (en) Process for preparation of prostaglandin derivatives and pharmceutical composition containing the compounds as effectual components
GB1520942A (en) Postaglandin analogues
WO1989009766A3 (en) Process for the preparation of 2,4,6-triiodo-5-amino-n-alkylisophthalamic acid
JPS52111547A (en) Prostaglandin analogous compounds, their preparation and pharmaceutica l component containing the same
JPS5285150A (en) Preparation of prostaglandin-like compounds
IE812355L (en) Prostaglandins

Legal Events

Date Code Title Description
MK9A Patent expired